| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/12/2001 | CA2386419A1 Method for preparing steroids modified by yeast fermentation |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386377A1 Cell targeting compositions and methods of using the same |
| 04/12/2001 | CA2386374A1 Methods for treatment of solid tumors and metastasis by gene therapy |
| 04/12/2001 | CA2386258A1 Adjustable sensitivity, genetic molecular interaction systems, including protein-protein interaction systems for detection and analysis |
| 04/12/2001 | CA2386252A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | CA2386248A1 Il13 mutants |
| 04/12/2001 | CA2386246A1 Altering gene expression with ssdna produced in vivo |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386236A1 Human inwardly rectifying potassium channel subunit |
| 04/12/2001 | CA2386199A1 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | CA2386192A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 04/12/2001 | CA2386189A1 Novel human membrane proteins |
| 04/12/2001 | CA2386185A1 Fibrinolytically active polypeptide |
| 04/12/2001 | CA2386111A1 Plant fatty acid desaturases and alleles therefor |
| 04/12/2001 | CA2386089A1 Diagnostic and therapeutic epitope and transgenic plant |
| 04/12/2001 | CA2386024A1 Liposome-entrapped dna oral vaccines |
| 04/12/2001 | CA2385984A1 Animal model for mesangial proliferative nephritis |
| 04/12/2001 | CA2385875A1 Gmp synthetase derived from plants |
| 04/12/2001 | CA2385853A1 Design of high affinity rnase h recruiting oligonucleotide |
| 04/12/2001 | CA2385823A1 Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| 04/12/2001 | CA2385709A1 Human antibodies |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385323A1 Cellulose films for screening |
| 04/12/2001 | CA2385220A1 Antisense compositions and cancer-treatment methods |
| 04/12/2001 | CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use |
| 04/12/2001 | CA2385045A1 Ifn-alpha homologues |
| 04/12/2001 | CA2385032A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 04/12/2001 | CA2384696A1 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | CA2382541A1 Dna library and its use in methods of selecting and designing polypeptides |
| 04/12/2001 | CA2380807A1 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/12/2001 | CA2353083A1 Method of constructing male sterile plant |
| 04/11/2001 | EP1091004A2 Simultaneous detection, identification and differentiation of Eubacterial taxa using a hybridization assay |
| 04/11/2001 | EP1091003A2 Improvements in or relating to detection of microorganisms in plant material |
| 04/11/2001 | EP1091002A2 Sequential activation of one or more enzymatic activities within a thermocycling reaction for synthesizing DNA molecules |
| 04/11/2001 | EP1091000A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 04/11/2001 | EP1090999A2 Plant with modified flowers |
| 04/11/2001 | EP1090998A1 Nucleotide sequences coding for the eno gene |
| 04/11/2001 | EP1090997A1 Hcv-derived rna polymerase gene |
| 04/11/2001 | EP1090996A1 Vector expressing the full-length gene of rna virus and use thereof |
| 04/11/2001 | EP1090995A2 Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof |
| 04/11/2001 | EP1090994A2 Peptide repeat immunogens |
| 04/11/2001 | EP1090993A1 Nucleotide sequences coding for the lrp gene |
| 04/11/2001 | EP1090992A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF |
| 04/11/2001 | EP1090991A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 04/11/2001 | EP1090990A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090988A1 Methods for the production of recombinant citrate lyase holo-enzyme |
| 04/11/2001 | EP1090987A1 Cell cycle regulatory factor |
| 04/11/2001 | EP1090986A1 Protein rim 2 |
| 04/11/2001 | EP1090985A1 Feline-derived T-cells |
| 04/11/2001 | EP1090927A1 Polypeptide (scFv) for the detection and removal of CA19-9 antigen positive cells |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090925A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090641A2 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 04/11/2001 | EP1090294A1 Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof |
| 04/11/2001 | EP1090286A1 Multi-sensor array for electrochemical recognition of nucleotide sequences and methods |
| 04/11/2001 | EP1090147A2 Method for detection of drug-selected mutations in the hiv protease gene |
| 04/11/2001 | EP1090146A1 Uses of dna-pk |
| 04/11/2001 | EP1090144A1 Method for detecting, analyzing, and mapping rna transcripts |
| 04/11/2001 | EP1090143A1 Method for quantifying tgf-beta |
| 04/11/2001 | EP1090138A1 Nucleotide detection method |
| 04/11/2001 | EP1090137A1 Production of polymers from nucleotidic and/or non-nucleotidic elements using enzymatic methods |
| 04/11/2001 | EP1090135A2 Methods to screen herbicidal compounds utilizing air synthetase from arabidopsis thaliana |
| 04/11/2001 | EP1090134A1 Plant selectable marker and plant transformation method |
| 04/11/2001 | EP1090133A2 Non-food crop plant bioreactor |
| 04/11/2001 | EP1090132A1 Methods for production of recombinant polypeptides |
| 04/11/2001 | EP1090131A1 HUMAN GLYCOPROTEASE-LIKE PROTEINS AND DNAs ENCODING THESE PROTEINS |
| 04/11/2001 | EP1090130A1 Protein c derivatives |
| 04/11/2001 | EP1090129A2 Overexpression of phytase genes in yeast systems |
| 04/11/2001 | EP1090128A1 Modified vitamin-k-dependent polypeptides |
| 04/11/2001 | EP1090127A1 Adh7 nucleotides |
| 04/11/2001 | EP1090126A1 Microbial preparation of substances from aromatic metabolism/iii |
| 04/11/2001 | EP1090125A2 Dna encoding methymycin and pikromycin |
| 04/11/2001 | EP1090124A2 MATERIALS AND METHODS FOR THE ALTERATION OF ENZYME AND ACETYL CoA LEVELS IN PLANTS |
| 04/11/2001 | EP1090123A2 Polyketides and their synthesis |
| 04/11/2001 | EP1090122A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 04/11/2001 | EP1090121A1 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms |
| 04/11/2001 | EP1090120A2 Propionibacterium vector |
| 04/11/2001 | EP1090119A2 Novel olfactory receptors and their uses |
| 04/11/2001 | EP1090118A2 Human signal peptide-containing proteins |
| 04/11/2001 | EP1090117A2 Differentially expressed genes in pancreatic cancer and displasia |
| 04/11/2001 | EP1090116A2 Transgenic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 04/11/2001 | EP1090115A2 Modularly constructed rna molecules having two sequence region types |
| 04/11/2001 | EP1090114A2 Structured antisense nucleic acid molecules |
| 04/11/2001 | EP1090113A1 Methods for transferring the capability to produce a natural product into a suitable production host |
| 04/11/2001 | EP1090112A1 Human arf-related proteins |
| 04/11/2001 | EP1090111A1 Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides |
| 04/11/2001 | EP1090110A2 Human vault rna |
| 04/11/2001 | EP1090108A1 Novel methods for rescue of rna viruses |
| 04/11/2001 | EP1090107A1 Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cells and hybridomas for their production |
| 04/11/2001 | EP1090039A1 Peptide composition as immunogen for the treatment of allergy |
| 04/11/2001 | EP1090038A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 04/11/2001 | EP1090036A2 Site specific protein modification by mutagenesis |
| 04/11/2001 | EP1090033A1 Particles of hcv envelope proteins: use for vaccination |
| 04/11/2001 | EP1090026A1 Diacylglycerol o-acyltransferase |
| 04/11/2001 | EP1090025A1 Antisense modulation of tnfr1 expression |
| 04/11/2001 | EP1090024A2 Method for producing polynucleotides with desired properties |